Search
for
Sort by
Research 391–420 of 1000+
- Antioxidation, Anti-Inflammation, and Regulation of SRD5A Gene Expression of Oryza sativa cv. Bue Bang 3 CMU Husk and Bran Extracts as Androgenetic Alopecia Molecular Treatment Substances
- Effect of a sphingolipid‐mimetic compound on the promotion of hair growth: A randomized, double‐blind, placebo‐controlled clinical trial
- Spironolactone in hidradenitis suppurativa: a single-center
- A Nonrandomized Clinical Trial Investigating Keratinocyte Growth Factor‐Hair Serum for the Prevention of Chemotherapy‐Induced Alopecia
- 856 Topical application of newly developed pseudoceramide improved both skin and hair barrier functions
- Synthesis of Spiro[cyclohexane-1,2?-[2H]indene] derivatives as inhibitors of steroid 5?-reductase
- Identification and dissection of an enhancer controlling epithelial gene expression in skin
- Understanding the evolving treatment landscape of hidradenitis suppurativa: An analysis of All of Us
- Expression of nicastrin, NICD1, and Hes1 in NCSTN knockout mice: implications for hidradenitis suppurativa, Alzheimer’s, and liver cancer
- Androgens and Antiandrogens
- Preparation and Optimization of Garlic Oil/Apple Cider Vinegar Nanoemulsion Loaded with Minoxidil to Treat Alopecia
- Clinical Use of Extracellular Vesicles in the Management of Male and Female Pattern Hair Loss: A Preliminary Retrospective Institutional Review Board Safety and Efficacy Study
- Impaired Notch‐MKP‐1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology
- Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients
- Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease
- Hidradenitis suppurativa lesions are associated with decreased collagen, decreased elastin, and increased neovascularization
- Hidradenitis suppurativa: A comparison of guidelines
- Viewpoint 6
- Hidradenitis Suppurativa Tunnels: Unveiling a Unique Disease Entity
- Proceedings of the Joint CHSF/HSF/EHSF pre‐WCD Hidradenitis Suppurativa Symposium
- Viewpoint 1
- Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
- Hidradenitis Suppurativa: From Physiopathologies to Targeted Therapeutics
- Hidradenitis Suppurativa: From Physiopathologies to Targeted Therapeutics
- The Roles of Keratinocytes in the Initiation, Progression and Maintenance of Hidradenitis Suppurativa
- Remolding Microenvironmental Homeostasis for Enhancing Regenerative Hypertrophic Scar Treatment Based on Functionalized Microneedles
- SARS‐COV2 Vaccination and Hidradenitis Suppurativa: Role of Vaccination in Disease Activity
- 496 Understanding the mechanism of action of secukinumab using lesional hidradenitis suppurativa skin organ culture
- LB922 CyTOF immune profiling uncovers sex- and race-specific differences and cellular biomarkers for biologic response in Hidradenitis suppurativa
- Hidradenitis suppurativa: a new therapeutic approach for an old disease